| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/06/2004 | WO2004038377A2 Method for diagnosing renal diseases or predispositions |
| 05/06/2004 | WO2004038007A2 Dna polymerases with reduced base analog detection activity |
| 05/06/2004 | WO2004037997A2 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof |
| 05/06/2004 | WO2004037989A2 Modified nucleotides and methods of labeling nucleic acids |
| 05/06/2004 | WO2004037979A2 Improved sso7-polymerase conjugate proteins |
| 05/06/2004 | WO2004037977A2 Use of chimeric nucleases to stimulate gene targeting |
| 05/06/2004 | WO2004037974A2 Fagopyritol synthase genes and uses thereof |
| 05/06/2004 | WO2004037972A2 Endogenous retrovirus up-regulated in prostate cancer |
| 05/06/2004 | WO2004037907A2 Luminescent metal ion complexes |
| 05/06/2004 | WO2004037852A2 Thymidylate synthase polymorphisms for use in screening for cancer susceptibility |
| 05/06/2004 | WO2004037847A2 Hiv envelope-cd4 complexes and hybrids |
| 05/06/2004 | WO2004037842A1 Novel synthetic nucleic acids whose sugar moieties have s-configuration |
| 05/06/2004 | WO2004037202A2 Gb virus c and methods of treating viral infections |
| 05/06/2004 | WO2004037192A2 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases |
| 05/06/2004 | WO2004037182A2 Active specific immunotherapy of cancer metastasis |
| 05/06/2004 | WO2003106631A3 Methods and compositions relating to labeled rna molecules that reduce gene expression |
| 05/06/2004 | WO2003101376A3 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
| 05/06/2004 | WO2003064469A8 Regulation of human hematopoietin receptor-like protein |
| 05/06/2004 | WO2002091995A8 Method to induce neovascular formation and tissue regeneration |
| 05/06/2004 | WO2002064737A3 Antisense modulation of protein phosphatase 2 catalytic subunit beta expression |
| 05/06/2004 | WO2002061113A9 Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation |
| 05/06/2004 | US20040088762 Comprises DNA for identification of nucleotide sequences associated with miniaturization of plants; insect resistance |
| 05/06/2004 | US20040087769 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/06/2004 | US20040087538 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 05/06/2004 | US20040087534 2-100 nucleotides containing >/= 1 unmethylated cytosine-guanine dinucleotide; antisense therapies; in vivo hybridization probes; viricides |
| 05/06/2004 | US20040087528 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia |
| 05/06/2004 | US20040087517 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 05/06/2004 | US20040087506 Methods of modulating FabH activity |
| 05/06/2004 | US20040087505 Agonists for coating medical devices; soluble biologics |
| 05/06/2004 | US20040086977 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 05/06/2004 | US20040086976 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 05/06/2004 | US20040086970 Novel cytokine receptors and nucleic acids encoding the same |
| 05/06/2004 | US20040086939 Joining triamine compound to support; forming pattern on support; high density layouts |
| 05/06/2004 | US20040086932 Universal gel and methods for use thereof |
| 05/06/2004 | US20040086923 Comprises polypeptide with carbamoyl phosphate synthase (CPS) activity for identifying modulators which prevent and/or treat cancer and metabolic disorders |
| 05/06/2004 | US20040086914 Binding using ligase |
| 05/06/2004 | US20040086912 Method for detecting foreign DNA in a host Genome |
| 05/06/2004 | US20040086890 DNA polymerases with reduced base analog detection activity |
| 05/06/2004 | US20040086880 Method of producing nucleic acid molecules with reduced secondary structure |
| 05/06/2004 | US20040086879 Tripartite molecular beacons |
| 05/06/2004 | US20040086866 Double stranded nucleic acid biochips |
| 05/06/2004 | EP1416017A1 Fluorescent nucleosides, nucleotides or polynucleotides containing a rhodamine dye |
| 05/06/2004 | EP1415995A2 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/06/2004 | EP1415994A1 Retinal pigmented epithelium derived neurotrophic factor |
| 05/06/2004 | EP1415001A2 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 05/06/2004 | EP1414845A2 Human secreted proteins |
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |
| 05/06/2004 | EP1272501B1 Process for the preparation of phosphorothioate triesters |
| 05/06/2004 | EP0983233B1 Reagent useful for synthesizing sulfurized oligonucleotide analogs |
| 05/06/2004 | CA2503247A1 Screening methods for identification of efficient pre-trans-splicing molecules |
| 05/06/2004 | CA2503038A1 Dna polymerases with reduced base analog detection activity |
| 05/06/2004 | CA2503027A1 Thymidylate synthase polymorphisms for use in screening for cancer susceptibility |
| 05/06/2004 | CA2502960A1 Active specific immunotherapy of cancer metastasis |
| 05/06/2004 | CA2501606A1 Method for diagnosing renal diseases or predispositions |
| 05/06/2004 | CA2497913A1 Use of chimeric nucleases to stimulate gene targeting |
| 05/06/2004 | CA2483550A1 Fagopyrum esculentum fagopyritol synthase gene and use thereof |
| 05/06/2004 | CA2482744A1 Hiv envelope-cd4 complexes and hybrids |
| 05/06/2004 | CA2468903A1 Endogenous retrovirus up-regulated in prostate cancer |
| 05/05/2004 | CN2614209Y Solid phase synthesizing apparatus |
| 05/05/2004 | CN1493699A Determination of one section vagina bucillus Gardner DNA sequence (2) specificity and its application |
| 05/05/2004 | CN1493698A Determination of one section vagina bacillus Gardner DNA sequence (3) specificity and its application |
| 05/05/2004 | CN1493596A Polypeptide-human programming cell death protein 22 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493595A Polypeptide-human tumour protein 20 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493594A Polypeptide-human signal peptide secretory protein I 10 and polynucleolide for coding said polypeptide |
| 05/05/2004 | CN1493593A Polypeptide-human transcription regulate and control protein 44 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493592A Polypeptide-respiratory protein 18 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493591A Polypeptide-human protein synthetic protein L14, 22 and nucleotide for coding said polypeptide |
| 05/05/2004 | CN1493590A Polypeptide-human cell disintegrate regulatory protein 27 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493589A Polypeptide-human cell regulate and control protein 54 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493588A Polyepeptide-human transcription regulate and control protein 35 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493587A Polypeptide-human protein regulatory protein s9 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493586A Polypeptide-human transcription regulate and control protein 38 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493585A Polypeptide-human tubulin monomer releasing factor 28 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493584A New polypeptide-human tumour inhibiting factor 46 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493583A New polypeptide-hyman glucoprotein 42 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493582A Cleaning convenient, high efficiency degradating method of nucleic acid |
| 05/05/2004 | CN1493581A EB virus antisense oligomeric deoxynucleotide and its application |
| 05/05/2004 | CN1493563A Serine/histamine acidamine and its preparation method and application |
| 05/05/2004 | CN1148381C New human chemotaxis factor macrophage inflammatory protein, its coding sequence and use |
| 05/04/2004 | US6730304 Viral nuceotide sequences for use in the diagnosis of viral diseases |
| 05/04/2004 | US6730301 Mediating chemotaxis and activation of monocytes; athero-sclerosis; monocyte chemoattractant protein-1 (mcp-1) |
| 05/04/2004 | US6730269 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 04/29/2004 | WO2004036219A1 Demethylated and/or oxidized membrane dna and use thereof in the diagnostic of autoimmune diseases |
| 04/29/2004 | WO2004036190A2 Compositions and methods for detecting west nile virus |
| 04/29/2004 | WO2004036184A2 Method for drying dye-terminator sequencing reagents |
| 04/29/2004 | WO2004035831A1 Method for identifying vehicle and oligonucleotide marker used therefor |
| 04/29/2004 | WO2004035819A2 Oligonucleotide analogues for detecting and analyzing nucleic acids |
| 04/29/2004 | WO2004035806A2 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene |
| 04/29/2004 | WO2004035764A2 PROTEIN SYNTHESIS WITH TANDEMLY ACTIVATED tRNAs |
| 04/29/2004 | WO2004035758A2 Rna-based inhibitory oligonucleotides |
| 04/29/2004 | WO2004035733A2 Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof |
| 04/29/2004 | WO2004035676A2 Antisense modulation of notch (drosophila) homolog 4 expression |
| 04/29/2004 | WO2004035611A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 04/29/2004 | WO2004035600A1 Method of manufacturing labelled oligonucleotide conjugates |
| 04/29/2004 | WO2004034991A2 Antisense modulation of fatty acid synthase expression |
| 04/29/2004 | WO2004034966A2 Substances for preventing and treating autoimmune diseases |
| 04/29/2004 | WO2004034789A1 Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer |
| 04/29/2004 | WO2004026109A3 Molecular targets of cancer and aging |
| 04/29/2004 | WO2004024757A3 Modified pna molecules |